MetaCap

Perspective Therapeutics Statistics

NYSE: CATXHealthcareMedical DevicesUSD

2.46+0.10 (+4.24%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Perspective Therapeutics by the numbers

Perspective Therapeutics has a market capitalization of $280.8 million based on 114.15M shares outstanding. With trailing EPS of $-1.39, Perspective Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.8% below its 50-day average and 31.8% below its 200-day average.

Average daily trading volume is 1.68M shares, or about $4.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CATX valuation vs. peer median

CATX compared with the median of 8 peer companies
MetricCATXPeer medianDifference
Market cap$280.81M$265.97M+6%
Avg. volume1.68M305.88K+448%

Peer median across 8 companies: QSI, MOBI, LAB, INFU, TLSI, TMCI, CLPT, ELMD.

Valuation

Market cap
$280.81M
P/E (TTM)
—
Forward P/E
—
EPS (TTM)
$-1.39
Shares outstanding
114.15M

Price and trading

Previous close
2.36
Open
2.37
Day range
2.32 – 2.51
52-week range
1.96 – 6.16
52-week change
-29.11%
50-day moving average
2.96
200-day moving average
3.61
Beta
—
Volume
1.29M
Average volume
1.68M

Dividends and events

Annual dividend
None
Dividend yield
—
Ex-dividend date
—
Next earnings date
Aug 10, 2026

Additional statistics

Market Cap
280.81M
Forward Pe
-2.40
Eps
-1.39
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
6.16
Week52 Low
1.96
Avg Volume
1.68M
Shares Outstanding
114.15M
Ma50
2.96
Ma200
3.61
Earnings Date
Aug 10, 2026
Pct From52w High
-60.06%
Pct From52w Low
25.51%

Related